149 related articles for article (PubMed ID: 18043937)
1. Liver transplantation as curative approach for advanced hepatocellular carcinoma: is it justified?
Obed A; Tsui TY; Schnitzbauer AA; Obed M; Schlitt HJ; Becker H; Lorf T
Langenbecks Arch Surg; 2008 Mar; 393(2):141-7. PubMed ID: 18043937
[TBL] [Abstract][Full Text] [Related]
2. How to decide about liver transplantation in patients with hepatocellular carcinoma: size and number of lesions or response to TACE?
Otto G; Schuchmann M; Hoppe-Lotichius M; Heise M; Weinmann A; Hansen T; Pitton MP
J Hepatol; 2013 Aug; 59(2):279-84. PubMed ID: 23587474
[TBL] [Abstract][Full Text] [Related]
3. Liver transplantation for advanced hepatocellular carcinoma using poor tumor differentiation on biopsy as an exclusion criterion.
DuBay D; Sandroussi C; Sandhu L; Cleary S; Guba M; Cattral MS; McGilvray I; Ghanekar A; Selzner M; Greig PD; Grant DR
Ann Surg; 2011 Jan; 253(1):166-72. PubMed ID: 21294289
[TBL] [Abstract][Full Text] [Related]
4. An active liver transplant programme for hepatocellular carcinoma in cirrhotic patients: is it justified?
Chui AK; Rao AR; McCaughan GW; Waugh R; Verran DJ; Koorey D; Painter D; Sheil AG
Clin Transplant; 1999 Dec; 13(6):531-5. PubMed ID: 10617245
[TBL] [Abstract][Full Text] [Related]
5. Outcome of supraselective transarterial chemoembolization in patients with hepatocellular carcinoma.
Heinzow HS; Meister T; Nass D; Köhler M; Spieker T; Wolters H; Domschke W; Domagk D
Scand J Gastroenterol; 2011 Feb; 46(2):201-10. PubMed ID: 20969491
[TBL] [Abstract][Full Text] [Related]
6. Survival and recurrence after liver transplantation versus liver resection for hepatocellular carcinoma: a retrospective analysis.
Otto G; Heuschen U; Hofmann WJ; Krumm G; Hinz U; Herfarth C
Ann Surg; 1998 Mar; 227(3):424-32. PubMed ID: 9527066
[TBL] [Abstract][Full Text] [Related]
7. Superselective transarterial chemoembolization vs hepatic resection for resectable early-stage hepatocellular carcinoma in patients with Child-Pugh class a liver function.
Hsu KF; Chu CH; Chan DC; Yu JC; Shih ML; Hsieh HF; Hsieh TY; Yu CY; Hsieh CB
Eur J Radiol; 2012 Mar; 81(3):466-71. PubMed ID: 21376495
[TBL] [Abstract][Full Text] [Related]
8. Transarterial Chemoembolization Prior to Liver Transplantation in Patients with Hepatocellular Carcinoma.
Hołówko W; Wróblewski T; Wojtaszek M; Grąt M; Kobryń K; Ziarkiewicz-Wróblewska B; Krawczyk M
Ann Transplant; 2015 Dec; 20():764-8. PubMed ID: 26712800
[TBL] [Abstract][Full Text] [Related]
9. Poor prognosis for hepatocellular carcinoma with transarterial chemoembolization pre-transplantation: retrospective analysis.
Li HL; Ji WB; Zhao R; Duan WD; Chen YW; Wang XQ; Yu Q; Luo Y; Dong JH
World J Gastroenterol; 2015 Mar; 21(12):3599-606. PubMed ID: 25834326
[TBL] [Abstract][Full Text] [Related]
10. Rationality and effectiveness of transarterial chemoembolization as an initial treatment for BCLC B stage HBV-related hepatocellular carcinoma.
Heng-jun G; Yao-jun Z; Min-shan C; Mei-xian C; Jun-ting H; Li X; Lau WY
Liver Int; 2014 Apr; 34(4):612-20. PubMed ID: 24028297
[TBL] [Abstract][Full Text] [Related]
11. Comparison of hepatic resection and transarterial chemoembolization for solitary hepatocellular carcinoma.
Zhang DZ; Wei XD; Wang XP
World J Gastroenterol; 2015 Apr; 21(15):4635-43. PubMed ID: 25914473
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and Safety of Combined Radiofrequency Ablation with Transarterial Chemoembolization in Patients with Barcelona Clinic Liver Cancer Stage A Hepatocellular Carcinoma Ineligible for Curative Treatment.
Kim AR; Park E; Kwon SY; Park SJ; Kim YJ; Yoo BC; Choe WH; Kim JH; Hwang JH; Park SW; Kim YJ; Park HS; Yu MH; Jeon HJ
Korean J Gastroenterol; 2019 Mar; 73(3):167-176. PubMed ID: 31013560
[TBL] [Abstract][Full Text] [Related]
13. The Munich-Transarterial Chemoembolisation Score Holds Superior Prognostic Capacities Compared to TACE-Tailored Modifications of 9 Established Staging Systems for Hepatocellular Carcinoma.
Op den Winkel M; Nagel D; Op den Winkel P; Paprottka PM; Schmidt L; Bourhis H; Trojan J; Goeller M; Reiter FP; Stecher SS; De Toni EN; Gerbes AL; Kolligs FT
Digestion; 2019; 100(1):15-26. PubMed ID: 30282074
[TBL] [Abstract][Full Text] [Related]
14. Prognostic effect of transarterial chemoembolization-induced complete pathological response in patients undergoing liver resection and transplantation for hepatocellular carcinoma.
Kang WH; Hwang S; Song GW; Lee YJ; Kim KH; Ahn CS; Moon DB; Jung DH; Park GC; Lee SG
Liver Transpl; 2017 Jun; 23(6):781-790. PubMed ID: 28240808
[TBL] [Abstract][Full Text] [Related]
15. Recipient Hepatic Tumor-Associated Immunologic Infiltrates Predict Outcomes After Liver Transplantation for Hepatocellular Carcinoma.
Atanasov G; Dino K; Schierle K; Dietel C; Aust G; Pratschke J; Seehofer D; Schmelzle M; Hau HM
Ann Transplant; 2020 Mar; 25():e919414. PubMed ID: 32165607
[TBL] [Abstract][Full Text] [Related]
16. Curative salvage liver transplantation in patients with cirrhosis and hepatocellular carcinoma: An intention-to-treat analysis.
de Haas RJ; Lim C; Bhangui P; Salloum C; Compagnon P; Feray C; Calderaro J; Luciani A; Azoulay D
Hepatology; 2018 Jan; 67(1):204-215. PubMed ID: 28806477
[TBL] [Abstract][Full Text] [Related]
17. Modern Outcomes Following Treatment of Hepatocellular Carcinoma in Hereditary Hemochromatosis: A Matched Cohort Study.
McPhail MJW; Khorsandi SE; Abbott L; Al-Kadhimi G; Kane P; Karani J; O'Grady J; Heaton N; Bomford A; Suddle A
Am J Clin Oncol; 2019 Dec; 42(12):918-923. PubMed ID: 31436748
[TBL] [Abstract][Full Text] [Related]
18. Liver resection for hepatocellular carcinoma: personal experiences in a series of 1330 consecutive cases in China.
Li J; Huang L; Yan J; Qiu M; Yan Y
ANZ J Surg; 2018 Oct; 88(10):E713-E717. PubMed ID: 29363237
[TBL] [Abstract][Full Text] [Related]
19. [New surgical approaches in the treatment of hepatocellular carcinoma].
Hoffmann K; Schmidt J
Z Gastroenterol; 2009 Jan; 47(1):61-7. PubMed ID: 19156593
[TBL] [Abstract][Full Text] [Related]
20. Transarterial chemoembolization versus resection for intermediate-stage (BCLC B) hepatocellular carcinoma.
Kim JY; Sinn DH; Gwak GY; Choi GS; Saleh AM; Joh JW; Cho SK; Shin SW; Carriere KC; Ahn JH; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
Clin Mol Hepatol; 2016 Jun; 22(2):250-8. PubMed ID: 27377909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
